PHARMARON UK LIMITED
Get an alert when PHARMARON UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-12-27 (in 7mo)
Last made up 2025-12-13
Watchouts
None on the register
Cash
£14M
-8.7% vs 2023
Net assets
£195M
+28% vs 2023
Employees
684
+8.4% vs 2023
Profit before tax
-£5M
-168.6% vs 2023
Name history
Renamed 2 times since incorporation
- PHARMARON UK LIMITED 2016-09-01 → present
- QUOTIENT BIORESEARCH GROUP LIMITED 2014-04-11 → 2016-09-01
- QBRG LIMITED 2013-10-30 → 2014-04-11
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £125,445,000 | £114,155,000 | |
| Operating profit | £7,140,000 | -£5,136,000 | |
| Profit before tax | £7,324,000 | -£5,023,000 | |
| Net profit | £6,092,000 | -£6,479,000 | |
| Cash | £15,494,000 | £14,147,000 | |
| Total assets less current liabilities | £207,416,000 | £232,526,000 | |
| Net assets | £152,597,000 | £195,350,000 | |
| Equity | £152,597,000 | £195,350,000 | |
| Average employees | 631 | 684 | |
| Wages | £36,550,000 | £40,272,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 5.7% | -4.5% | |
| Net margin | 4.9% | -5.7% | |
| Return on capital employed | 3.4% | -2.2% | |
| Gearing (liabilities / total assets) | 41.5% | 30.6% | |
| Current ratio | 0.99x | 2.72x | |
| Interest cover | 3.25x | -1.83x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Standalone (parent only)
- Auditor
- Azets Audit Services
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on the going concern basis. The Company is financially supported by ultimate parent Company for at least 12 months from the date of approval of these financial statements. This should enable the Company to continue in operational existence for the foreseeable future by meeting its liabilities as they fall due for payment.”
Group structure
- PHARMARON UK LIMITED · parent
- Quotient Bioresearch (Radiochemicals) Limited 100%
- Pharmaron Manufacturing Services Limited 100%
Significant events
- “On 2nd January 2025, the Company sold its wholly owned subsidiary, Pharmaron Manufacturing Services Ltd, for its book value of £78,107,193.43.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 8 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| LEWINTON, Stephen Christopher | Secretary | 2016-02-02 | — | — |
| LEWINTON, Stephen Christopher, Mr. | Director | 2022-11-04 | Apr 1966 | British |
| LOU, Boliang, Dr | Director | 2016-02-02 | Sep 1963 | American |
Show 8 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BURDETT, Roger Leonard | Director | 2013-10-30 | 2016-02-02 |
| CAMERON, Gordon | Director | 2013-10-30 | 2016-02-02 |
| CARTER, Mark | Director | 2013-12-10 | 2016-02-02 |
| EGERTON, Mark, Dr. | Director | 2013-12-10 | 2016-02-02 |
| GOLDSTEIN, Jonathan | Director | 2013-12-10 | 2016-02-02 |
| HEMMINGS, Simon Robert | Director | 2015-01-05 | 2016-02-02 |
| LEWINTON, Stephen Christopher, Mr. | Director | 2013-12-10 | 2016-03-23 |
| PLEASANCE, Stephen, Dr | Director | 2013-12-10 | 2016-02-02 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Dr. Boliang Lou | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2020-12-02 | Active |
| Xiaoqiang Lou | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2020-12-02 | Active |
| Bei Zheng | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2020-12-02 | Active |
| Mr Boliang Lou | Individual | Appoints directors | 2016-04-06 | Ceased 2022-11-04 |
Filing timeline
Last 20 of 93 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-04-07 RESOLUTIONS Resolution
- 2024-04-07 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-24 | SH01 | capital | Capital allotment shares | |
| 2025-12-16 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-10-02 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2025-10-02 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2025-07-29 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-07-29 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-07-28 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-07-28 | PSC09 | persons-with-significant-control | Withdrawal of a person with significant control statement | |
| 2025-05-08 | AA | accounts | Accounts with accounts type full | |
| 2024-12-20 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-08-12 | SH01 | capital | Capital allotment shares | |
| 2024-07-08 | AA | accounts | Accounts with accounts type full | |
| 2024-04-07 | RESOLUTIONS | resolution | Resolution | |
| 2024-04-07 | RESOLUTIONS | resolution | Resolution | |
| 2024-04-03 | SH01 | capital | Capital allotment shares | |
| 2023-12-14 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-08-30 | AA | accounts | Accounts with accounts type full | |
| 2022-12-23 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-12-23 | AD02 | address | Change sail address company with old address new address | |
| 2022-12-22 | AD04 | address | Move registers to registered office company with new address |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 9
- Capital events
- 2
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-9%
£125,445,000 £114,155,000
-
Cash
-8.7%
£15,494,000 £14,147,000
-
Net assets
+28%
£152,597,000 £195,350,000
-
Employees
+8.4%
631 684
-
Operating profit
-171.9%
£7,140,000 -£5,136,000
-
Profit before tax
-168.6%
£7,324,000 -£5,023,000
-
Wages
+10.2%
£36,550,000 £40,272,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers